Departamento de Bioquímica, Universidade Federal de Pernambuco, Recife, Pernambuco, Brazil.
Faculdade de Farmácia, Universidade Federal Do Rio Grande Do Sul, Porto Alegre, Rio Grande do Sul, Brazil.
Microb Pathog. 2019 Jun;131:150-157. doi: 10.1016/j.micpath.2019.04.009. Epub 2019 Apr 6.
In this study, essential oil extracted from Syagrus coronata seeds (SCEO) was evaluated for antibacterial and antibiofilm activities against Staphylococcus aureus; in addition, Galleria mellonella model was used as an in vivo infection model. SCEO was mainly composed by fatty acids (89.79%) and sesquiterpenes (8.5%). The major components were octanoic acid, dodecanoic acid, decanoic acid and γ-eudesmol. SCEO showed bactericidal activity (minimal bactericidal concentration from 312 to 1250 μg/mL) against all tested S. aureus clinical isolates, which showed distinct biofilm-forming and multiple drug resistance phenotypes. SCEO weakly reduced biomass but remarkably decreased cell viability in pre-formed biofilms of S. aureus isolate UFPEDA-02 (ATCC-6538). Electron microscopy analysis showed that SCEO treatments decreased the number of bacterial cells (causing structural alterations) and lead to loss of the roughness in the multiple layers of the three-dimensional biofilm structure. In addition, overproduction of exopolymeric matrix was observed. SCEO at 31.2 mg/kg improved the survival of G. mellonela larvae inoculated with UFPEDA-02 isolate and reduced the bacterial load in hemolymph and melanization. In conclusion, SCEO is an antibacterial agent against S. aureus strains with different resistance phenotypes and able to disturb biofilm architecture. Our results show SCEO as a potential candidate to drug development.
在这项研究中,评估了从 Syagrus coronata 种子中提取的精油(SCEO)对金黄色葡萄球菌的抗菌和抗生物膜活性;此外,还使用了 Galleria mellonella 模型作为体内感染模型。SCEO 主要由脂肪酸(89.79%)和倍半萜烯(8.5%)组成。主要成分是辛酸、十二酸、癸酸和γ-桉叶醇。SCEO 对所有测试的金黄色葡萄球菌临床分离株均表现出杀菌活性(最低杀菌浓度为 312 至 1250μg/ml),这些分离株表现出明显的生物膜形成和多种药物耐药表型。SCEO 虽然对金黄色葡萄球菌分离株 UFPEDA-02(ATCC-6538)的生物膜生物量有较弱的减少作用,但显著降低了其细胞活力。电子显微镜分析表明,SCEO 处理减少了细菌细胞的数量(导致结构改变),并导致三维生物膜结构的多层粗糙度丧失。此外,还观察到胞外聚合基质的过度产生。SCEO 以 31.2mg/kg 的剂量提高了接种 UFPEDA-02 分离株的 G. mellonela 幼虫的存活率,并降低了血淋巴中的细菌负荷和黑化。总之,SCEO 是一种针对具有不同耐药表型的金黄色葡萄球菌菌株的抗菌剂,能够干扰生物膜结构。我们的结果表明,SCEO 是药物开发的潜在候选物。